Jacqui M. Hall

Senior Counsel

Overview

Jacqui Hall’s 20+ years of experience supporting biopharmaceutical and technology industries, including as in-house counsel, enables her to provide strategic and pragmatic counsel on a range of transactional matters.

Jacqui helps clients with complex manufacturing and supply chain agreements, license and research agreements with academic counterparties, and software and other technology-related agreements.

Career & Education

    • Contracts Manager, Novartis Pharmaceuticals Corporation
      • Handled a broad range of transactions including licensing of biotechnology and software technologies
      • Helped develop internal guidance on negotiating clinical trial agreements
    • In-house Counsel, Millennium Pharmaceuticals, Inc. (now Takeda Pharmaceutical Company Limited)
      • Handled a broad range of transactions including licensing of biotechnology and software technologies
      • Drafted a variety of consulting, service, and manufacturing agreements
    • Contracts Manager, Novartis Pharmaceuticals Corporation
      • Handled a broad range of transactions including licensing of biotechnology and software technologies
      • Helped develop internal guidance on negotiating clinical trial agreements
    • In-house Counsel, Millennium Pharmaceuticals, Inc. (now Takeda Pharmaceutical Company Limited)
      • Handled a broad range of transactions including licensing of biotechnology and software technologies
      • Drafted a variety of consulting, service, and manufacturing agreements
    • College of the Holy Cross, B.A.
    • Suffolk University Law School, J.D., cum laude
    • College of the Holy Cross, B.A.
    • Suffolk University Law School, J.D., cum laude
    • Massachusetts
    • New York
    • New Jersey
    • Massachusetts
    • New York
    • New Jersey

Representative Matters

  • Counseled ex-U.S. portfolio company on its services agreement with ex-U.S. CDMO for IND-enabling development and GMP manufacture of drug substance, and associated cell line license agreement, including royalty and milestone payment structure.
  • Regularly advises clients ranging from early stage to those with marketed product on their services/supply agreements for development and manufacture of GMP material, including biologics.
  • Drafted and negotiated multiple in-licenses of patent rights from top academic U.S. institution on behalf of major Boston-based venture capital backed portfolio companies.
  • Represents clients on sponsored research agreements and MTAs with academic institutions in U.S. and ex-U.S. for research using client proprietary materials.
  • Strategically counsels clients on agreements for client evaluation of proprietary industry materials and intellectual property.
  • Represented UK-based client transitioning to a clinical stage company on a SaaS agreement for a data analytics platform.